Is ending smoking and nicotine use at the same time a realistic public health goal at the population level? How can THR be successfully incorporated into tobacco control? What are the influencing factors that impact public risk perceptions on both smoking and nicotine use and how can messages to promote vaping cessation encourage quitting without… Read more »
Archives: Seminars
Closing Thoughts & Summit Close
Vaping-smoking transitions: a focus on the evidence
Much of the debate around the potential public health benefits and harms of e-cigarettes focuses on their relationship to smoking. If – at a population level – e-cigarettes lead to more people smoking than would have otherwise, then their net impact on public health will undoubtedly be a negative one. If, however, vaping decreases smoking… Read more »
Changing Nicotine Beliefs: Key to Changing Tobacco and Nicotine Use Behaviors?
Widespread misperceptions of the health risks of nicotine undermine use of nicotine replacement therapy for smoking cessation, and potentially, switching from combusted to non-combusted tobacco and nicotine products. They may also impact the public health benefits of FDA’s actions, including modified risk tobacco product (MRTP) authorizations and a reduced nicotine product standard for cigarettes. Dr…. Read more »
Effectiveness of a vaping cessation text message program among a diverse and high risk sample of adolescent e-cigarette users
E-cigarettes have been the most commonly used tobacco product among adolescents in the United States for nearly a decade. There is broad consensus that adolescents should not use any form of tobacco product, and yet there are no published studies of vaping cessation interventions for teens. This presentation will describe the results of a randomized,… Read more »
The future mortality implications of vaping for adolescents
The most serious potential adverse consequence of vaping by adolescents would be future mortality associated with long-term vaping itself or with vaping-induced cigarette smoking – the gateway effect. Whether the gateway effect exists remains a contentious issue. For the purposes of this analysis, we will assume that it does. We assume, as well, that vaping… Read more »
E-cigarettes for harm reduction: Starting with priority populations
This session will look at the role of e-cigarettes as a harm reduction strategy for high priority individuals, specifically those with high smoking prevalence or with the most immediate risk of particular health harm. Smoking cessation is the most effective means of slowing the decline of lung function associated with chronic obstructive pulmonary disease (COPD)… Read more »
Getting e-cigarettes into the tobacco treatment toolkit: Moving the medical community from “Should we?” to “How do we and for whom?”
The accumulating evidence now supports a strong conclusion that e-cigarettes are tools that health care clinicians can—and should—use to help adults stop smoking, especially those who cannot quit another way or who want to reduce health harm without quitting. It is time for the medical community to add e-cigarettes to the tobacco treatment toolbox. The… Read more »
England’s national “Swap to Stop” program
In April 2023 England’s Minister for Public Health announced an ambitious national Swap to Stop scheme through which 1 million smokers will be supported to quit smoking through the use of an E-Cigarette, this presentation will review the evidence and update on progress including highlighting the targeted way the scheme is seeking to reduce health… Read more »
Cigarette smoking relapse among recent former smokers who switched to e-cigarettes or other tobacco products
Electronic cigarettes (or e-cigarettes) have been studied as a cessation tool in clinical trials and longitudinal studies. Less well-studied is how e-cigarette use among former smokers affects smoking relapse, a concept that is not well-defined. A recent paper looked at this issue but only used any cigarette smoking in the past 12 months as their… Read more »
Recent Comments